COMMUNIQUÉS West-GlobeNewswire

-
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference
19/02/2025 -
Lifeward Announces CEO Transition
19/02/2025 -
SANUWAVE Health to Participate in 37th Annual Roth Conference
19/02/2025 -
Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution
19/02/2025 -
Inaugural Eye Health Summit Empowers Public with Integrative Vision Care Insights from Leading Experts
19/02/2025 -
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
19/02/2025 -
Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
19/02/2025 -
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
19/02/2025 -
Le Centre C3i, une compagnie canadienne, reçoit l'approbation de l’EMA pour fabriquer des produits de thérapie cellulaire pour le marché européen
19/02/2025 -
Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
19/02/2025 -
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
18/02/2025 -
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
18/02/2025 -
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
18/02/2025 -
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
18/02/2025 -
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
18/02/2025 -
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
18/02/2025 -
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
18/02/2025 -
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
18/02/2025 -
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
18/02/2025
Pages